Walleye Capital’s ANI Pharmaceuticals ANIP Stock Holding History
Bought
Maintained
Sold
Other funds holding ANIP
Walleye Capital's ANIP Position: Q3 2026 in Review
Walleye Capital reduced its ANI Pharmaceuticals (ANIP) stake by 82% in Q3 2026, selling an estimated $6.69M and leaving 19,245 shares worth $1.4M. The position accounts for ﹤0.01% of the portfolio, ranked #3156.
Walleye Capital first reported a position in ANIP in Q1 2019 and has held it in 15 quarters since. The position peaked at $19.8M in Q3 2025. 289 funds tracked by Wall St. Rank hold ANIP as of Q3 2026.
- Walleye Capital held 19,245 shares of ANI Pharmaceuticals worth $1.4M as of Q3 2026.
- Walleye Capital sold 86,867 ANI Pharmaceuticals shares in Q3 2026, an estimated $6.69M.
- ANI Pharmaceuticals made up ﹤0.01% of Walleye Capital's portfolio in Q3 2026, its #3156 holding.
- Walleye Capital first reported a position in ANI Pharmaceuticals in Q1 2019 and has held it in 15 quarters since.
- Walleye Capital's ANI Pharmaceuticals position peaked at $19.8M in Q3 2025.
- 289 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q3 2026.
Based on Walleye Capital's 13F filing for Q3 2026, filed 13 Nov 2026.